DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.
Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
Based on Molecule Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
- Small Molecules
- Large Molecules
- LC-MS Studies
- Immunoassays
- Other Large Molecule Tests
Based Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
- Bioavailability and Bioequivalence Studies
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
- Absorption, Distribution, Metabolism, Excretion (ADME)
- Other Applications
By Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
- Cell-based Assays
- Bacterial Cell-based Assays
- Viral Cell-based Assays
- Virology Testing
- In Vitro Virology Testing
- In Vivo Virology Testing
- Species-Specific Viral PCR Assays
- Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
- Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
- Viral Serology, Immunogenicity, and Neutralizing Antibodies
- Method Development Optimization and Validation (MDOV)
- Biomarker Testing
- Pharmacokinetic Testing
- Other Test Types
By Workflow Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
- Sample Preparation
- Protein Precipitation
- Liquid-liquid Extraction (LLE)
- Sample Analysis
- Hyphenated Technique
- Chromatographic Technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
- Other Workflow Processes
By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
- Oncology
- Neurology
- Infectious Diseases
- Gastroenterology
- Cardiology
- Other Therapeutic Areas
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
- Pharma and Biopharma Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Contract Research Organizations (CROs)
Selected Key Players:
- Charles River Laboratories International Inc.
- Covance Inc.
- Eurofins Scientific
- ICON PLC
- Intertek Group PLC
- IQVIA Holdings, Inc.
- Laboratory Corporation of America Holdings
- Medpace Holdings, Inc.
- Pace Analytical Services LLC.
- Parexel International Corporation
- PPD Inc.
- SGS SA
- Syneos Health, LLC
- Toxikon Corporation
- WuXi Apptech Co., Ltd.
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of Asia Pacific Market by Molecule Type
4 Segmentation of Asia Pacific Market by Application
5 Segmentation of Asia Pacific Market by Test Type
6 Segmentation of Asia Pacific Market by Workflow Process
7 Segmentation of Asia Pacific Market by Therapeutic Area
8 Segmentation of Asia Pacific Market by End User
9 Asia-Pacific Market 2021-2031 by Country
10 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/xxq5rt
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900